日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LncRNA Wee1-AS coordinates oxidative fatty acid metabolism through the activation of mitochondrial CDK1/CYCLIN B1

lncRNA Wee1-AS 通过激活线粒体 CDK1/CYCLIN B1 来协调氧化脂肪酸代谢

Kim, Hyeon-Ji; Jeong, Cheolhee; Lee, Sang-Heon; An, Seungchan; Hyun, Gyu Hwan; Lim, Ga Young; Kim, Ju-Yeon; Lee, Junhyeong; Park, Min-Jung; Kwon, Sung Won; Kim, Won; Noh, Minsoo; Han, Yong-Hyun; Lee, Mi-Ock

Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors

靶向 CDK12/13 可诱导有丝分裂停滞,从而克服对 KRASG12C 抑制剂的耐药性

Stern, Yaakov E; Ghosh, Pompom; Peroza, John; Solanki, Hitendra S; Imbody, Denis; Bridenstine, Liznair; Pandurangan, Thiyagamurthy; Frydman, Sylvia M; Nickens, Kathryn N; Walker-Mimms, Hannah L; Suvarna, Kruthi; Chaudhary, Neelkamal; Monastyrskyi, Andrii; Duckett, Derek; Haura, Eric B

NUDT21-mediated Alternative Polyadenylation of CDK19 Reprograms Cholesterol Biosynthesis to Drive Colorectal Cancer Progression

NUDT21介导的CDK19替代性多聚腺苷酸化重编程胆固醇生物合成以驱动结直肠癌进展

Yu, Yeping; Ma, Jixin; Zhou, Minwei; Gu, Xiaodong; Zhou, Yiming; Li, Zhenyang; Zhang, Tianyu; Gong, Wei; Huang, Chuanxin; Xiang, Jianbin

CDK13 drives clear cell renal carcinoma through METTL16-mediated m(6)A modification of ACLY mRNA

CDK13 通过 METTL16 介导的 ACLY mRNA 的 m(6)A 修饰驱动透明细胞肾细胞癌的发生

Chen, Jinsuo; Liu, Huan; Zhang, Yong; Gu, Junfei; Wu, Xiaoli; Xuan, Fan; Qu, Changbao; Sun, Hao; Yue, Nanxi; Yang, Chenxiao; Zhao, Hongye; Yang, Wenzeng; Yang, Zhan

Methyl-cantharidimide suppresses cyclin-dependent kinase 1 (CDK1) and induces oxeiptosis in liver cancer

甲基斑蝥酰亚胺抑制细胞周期蛋白依赖性激酶1 (CDK1) 并诱导肝癌细胞发生氧化性凋亡

Li, Yi-Dong; Chen, Xiang; Dong, Xing-Duo; Ding, Zhiyong; Chen, Zhe-Sheng; Fang, Shuo

Oncogenic GPRIN1 sustains proliferation and mitochondrial homeostasis via dual‑layer CDK1-PI3K/Akt signalling in gallbladder cancer.

致癌基因 GPRIN1 通过双层 CDK1-PI3K/Akt 信号通路维持胆囊癌的增殖和线粒体稳态。

Xu Chang, Gong Zijun, Ni Xiaojian, Nan Lingxi, Sun Wentao, Liu Houbao, Luo Xuanming, Li Min

RE: Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer

回复:靶向 CDK12 可破坏晚期 ER+ 乳腺癌中雌激素受体染色质募集和 ER-MED1 转录

Lehrer, Steven

Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer

靶向 CDK12 会破坏晚期 ER+ 乳腺癌中雌激素受体染色质募集和 ER-MED1 转录

Ottaviani, Daniela; Ola, Mihaela; Allotta, Alessandra; Maati Chaibi, Yasmine; Hickey, Seán; Jagust, Petra; Cosgrove, Nicola; Cocchiglia, Sinéad; Bane, Fiona; Fallon, Ramón; Daly, Gordon; Hegarty, Aisling; Hudson, Lance; Sheehan, Katherine; Kalsi, Shannon; Shovlin, Stephen; Powell, Aoibhín; Bahl, Ash; Ainscow, Ed; Oesterreich, Steffi; Lee, Adrian V; Couch, Fergus J; Hill, Arnold D K; Varešlija, Damir; Young, Leonie

Single-cell RNA-Seq reveals transcriptional heterogeneity in sepsis and down-regulation of SNHG5/miR-324-5p/CDK16 axis in T cells.

单细胞 RNA 测序揭示了脓毒症中的转录异质性以及 T 细胞中 SNHG5/miR-324-5p/CDK16 轴的下调。

Zhang Jinxin, Fu Heliang, Liu Shanshou, Xie Jiangang, Zhao Shunzhong, Wang Xianqi, Wang Qianmei, Hu Shanbo, Zhao Peng, Chen Jijun, Li Junjie, Yin Wen

CDK12 Inactivation Attenuates Prostate Cancer Progression by Inhibiting BNIP3-Mediated Mitophagy

CDK12失活通过抑制BNIP3介导的线粒体自噬来减缓前列腺癌的进展

Huang, Mengjun; Lei, Hanqi; Tong, Tongyu; Zou, Hailin; Yan, Binyuan; Cao, Fei; Wang, Yiting; Teng, Qiliang; Xu, Bin; Luo, Juan; Guan, Yupeng; Lai, Shaohong; Li, Peng; Pang, Jun